These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32602053)

  • 1. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
    Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
    J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R
    J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
    Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
    Front Immunol; 2021; 12():631298. PubMed ID: 33732252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to mycobacterial disease due to mutations in IL-12Rβ1 in three Iranian patients.
    Alinejad Dizaj M; Mortaz E; Mahdaviani SA; Mansouri D; Mehrian P; Verhard EM; Varahram M; Babaie D; Adcock IM; Garssen J; van de Vosse E; Velayati A
    Immunogenetics; 2018 Jun; 70(6):373-379. PubMed ID: 29256176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M
    J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity.
    Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M
    Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
    Peñafiel Vicuña AK; Yamazaki Nakashimada M; León Lara X; Mendieta Flores E; Nuñez Núñez ME; Lona-Reyes JC; Hernández Nieto L; Ramírez Vázquez MG; Barroso Santos J; López Iñiguez Á; González Y; Torres M; Lezana Fernández JL; Román Montes CM; Medina-Torres EA; González Serrano E; Bustamante Ogando JC; Lugo Reyes S; Zavaleta Martínez O; Staines Boone AT; Venegas Montoya E; Aguilar Gómez NE; Soudeé C; Jouanguy E; Puel A; Boisson-Dupuis S; Pedraza Sánchez S; Casanova JL; Espinosa Rosales F; Espinosa Padilla S; Bustamante J; Blancas Galicia L
    J Clin Immunol; 2023 Jan; 43(1):123-135. PubMed ID: 36044171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian susceptibility to mycobacterial disease: recent discoveries.
    Bustamante J
    Hum Genet; 2020 Jun; 139(6-7):993-1000. PubMed ID: 32025907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.
    Döffinger R; Altare F; Casanova JL
    Microbes Infect; 2000 Nov; 2(13):1553-7. PubMed ID: 11113374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
    Döffinger R; Dupuis S; Picard C; Fieschi C; Feinberg J; Barcenas-Morales G; Casanova JL
    Mol Immunol; 2002 May; 38(12-13):903-9. PubMed ID: 12009568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
    Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
    Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections.
    Sanal O; Turul T; De Boer T; Van de Vosse E; Yalcin I; Tezcan I; Sun C; Memis L; Ottenhoff TH; Ersoy F
    J Clin Immunol; 2006 Jan; 26(1):1-6. PubMed ID: 16418797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
    Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
    Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mendelian susceptibility to mycobacterial diseases: state of the art.
    Noma K; Mizoguchi Y; Tsumura M; Okada S
    Clin Microbiol Infect; 2022 Nov; 28(11):1429-1434. PubMed ID: 35283318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian susceptibility to mycobacterial disease: 2014-2018 update.
    Rosain J; Kong XF; Martinez-Barricarte R; Oleaga-Quintas C; Ramirez-Alejo N; Markle J; Okada S; Boisson-Dupuis S; Casanova JL; Bustamante J
    Immunol Cell Biol; 2019 Apr; 97(4):360-367. PubMed ID: 30264912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic features of IL12Rb1 deficiency: Single center experience of 18 patients.
    Tan Ç; Çağdaş-Ayvaz D; Metin A; Keskin Ö; Tezcan İ; Sanal Ö
    Turk J Pediatr; 2016; 58(4):356-361. PubMed ID: 28276206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of IFN-γR1 (CD119) and IL-12Rβ1 (CD212) Deficiency by Flow Cytometry].
    Gelmez MY; Köksalan K; Çınar S; Hatipoğlu N; Coşkuner T; Topkarcı Z; Hançerli Törün S; Demirbuğa A; Yücel E; Kıykım A; Çokuğraş HC; Gemici-Karaaslan HB; Kendir-Demirkol Y; Deniz G
    Mikrobiyol Bul; 2023 Jan; 57(1):83-96. PubMed ID: 36636848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China.
    Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X
    J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients.
    Ben-Mustapha I; Ben-Ali M; Mekki N; Patin E; Harmant C; Bouguila J; Elloumi-Zghal H; Harbi A; Béjaoui M; Boughammoura L; Chemli J; Barbouche MR
    Immunogenetics; 2014 Jan; 66(1):67-71. PubMed ID: 24127073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.